⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TCRX News
TScan Therapeutics, Inc. Common Stock
TScan Therapeutics Announces Positive Updated Data from the ALLOHA™ Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition
globenewswire.com
TCRX
Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points
prnewswire.com
GTBP
GERN
KURA
SLS
TCRX
TScan Therapeutics to Host Virtual KOL Event to Discuss Clinical Updates from the ALLOHA™ Phase 1 Trial and Future Market Opportunities
globenewswire.com
TCRX
TScan Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
globenewswire.com
TCRX
TScan Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
globenewswire.com
TCRX
TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027
globenewswire.com
TCRX